{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:56:57Z","timestamp":1781701017073,"version":"3.54.5"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170331"],"award-info":[{"award-number":["82170331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400294"],"award-info":[{"award-number":["82400294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2025.117656","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:08:26Z","timestamp":1766102906000},"page":"117656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IL-18 potentiates platelet activation and thrombosis through IL-18R\u03b1-dependent MAPKs and PI3K\/Akt signaling"],"prefix":"10.1016","volume":"245","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0797-9458","authenticated-orcid":false,"given":"Maieryemu","family":"Waresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Can","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengsha","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanhan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6754-1432","authenticated-orcid":false,"given":"Xiaogang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.bcp.2025.117656_b0005","first-page":"785","article-title":"Thrombosis and platelets: an update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur. Heart J."},{"issue":"25","key":"10.1016\/j.bcp.2025.117656_b0010","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117656_b0015","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41569-018-0110-0","article-title":"Platelet biology and functions: new concepts and clinical perspectives","volume":"16","author":"van der Meijden","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"22","key":"10.1016\/j.bcp.2025.117656_b0020","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJM199005313222201","article-title":"Platelet hyperreactivity and prognosis in survivors of myocardial infarction","volume":"322","author":"Trip","year":"1990","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.bcp.2025.117656_b0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1093\/eurheartj\/ehv718","article-title":"Disordered haematopoiesis and athero-thrombosis","volume":"37","author":"Murphy","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.bcp.2025.117656_b0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2006.10.050","article-title":"Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?","volume":"49","author":"Bliden","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117656_b0035","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jacc.2014.06.1170","article-title":"Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease","volume":"64","author":"Angiolillo","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117656_b0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41569-023-00946-3","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","volume":"21","author":"Toldo","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117656_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25021082","article-title":"The role of pro-inflammatory cytokines in the pathogenesis of cardiovascular disease","volume":"25","author":"Zhang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.bcp.2025.117656_b0050","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/01.CIR.99.16.2079","article-title":"Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events","volume":"99","author":"Biasucci","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0055","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2011.03.015","article-title":"Interleukin 18 and coronary heart disease: prospective study and systematic review","volume":"217","author":"Jefferis","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/CP9.0000000000000037","article-title":"Metabolism, inflammation, and cardiovascular diseases from basic research to clinical practice","volume":"8","author":"Huang","year":"2023","journal-title":"Cardiology plus"},{"issue":"12","key":"10.1016\/j.bcp.2025.117656_b0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.bcp.2025.117656_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413505","article-title":"IL-18 and IL-18BP: a unique dyad in health and disease","volume":"25","author":"Novick","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.bcp.2025.117656_b0075","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000099509.76044.A2","article-title":"Interleukin-18 and the risk of coronary heart disease in European men: the prospective Epidemiological Study of Myocardial Infarction (PRIME)","volume":"108","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijcard.2003.08.020","article-title":"Serum levels of interleukin-18 in patients with stable and unstable angina pectoris","volume":"98","author":"Rosso","year":"2005","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.bcp.2025.117656_b0090","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.105.590927","article-title":"Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.bcp.2025.117656_b0095","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/ATVBAHA.107.149245","article-title":"Free Interleukin (IL)-18 levels, and the impact of IL18 and IL18BP genetic variation, in CHD patients and healthy men","volume":"27","author":"Thompson","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"14","key":"10.1016\/j.bcp.2025.117656_b0100","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Mallat","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2025.117656_b0105","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(-\/-) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.bcp.2025.117656_b0110","doi-asserted-by":"crossref","first-page":"E41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2025.117656_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114822","article-title":"NOD2-mediated P2Y(12) upregulation increases platelet activation and thrombosis in sepsis","volume":"194","author":"Zhong","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117656_b0125","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09537104.2021.1913576","article-title":"Release of \u03b1-granule contents during platelet activation","volume":"33","author":"Smith","year":"2022","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.bcp.2025.117656_b0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5482\/HAMO-16-07-0023","article-title":"Platelet granules - secretory and secretive","volume":"37","author":"Jurk","year":"2017","journal-title":"Hamostaseologie"},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13045-019-0709-6","article-title":"Platelet integrin \u03b1IIb\u03b23: signal transduction, regulation, and its therapeutic targeting","volume":"12","author":"Huang","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117656_b0140","first-page":"162","article-title":"New concepts and mechanisms of platelet activation signaling","volume":"32","author":"Estevez","year":"2017","journal-title":"Physiology (Bethesda)"},{"issue":"3","key":"10.1016\/j.bcp.2025.117656_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0150","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4049\/jimmunol.166.1.148","article-title":"Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain","volume":"166","author":"Kim","year":"2001","journal-title":"J. Immunol."},{"issue":"41","key":"10.1016\/j.bcp.2025.117656_b0155","doi-asserted-by":"crossref","first-page":"25737","DOI":"10.1074\/jbc.272.41.25737","article-title":"Purification and characterization of the human interleukin-18 receptor","volume":"272","author":"Torigoe","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"45","key":"10.1016\/j.bcp.2025.117656_b0160","doi-asserted-by":"crossref","first-page":"29445","DOI":"10.1074\/jbc.273.45.29445","article-title":"Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling","volume":"273","author":"Born","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2025.117656_b0165","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.1161\/CIRCRESAHA.122.321787","article-title":"IL-37 attenuates platelet activation and thrombosis through IL-1R8 pathway","volume":"132","author":"Chen","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.117656_b0170","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cyto.2016.10.016","article-title":"Differential synthesis and release of IL-18 and IL-18 Binding Protein from human platelets and their implications for HIV infection","volume":"90","author":"Allam","year":"2017","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.bcp.2025.117656_b0175","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/blood.2025028739","article-title":"Platelet NLRP6 protects against microvascular thrombosis in sepsis","volume":"146","author":"Jiang","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0180","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2025.117656_b0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117656_b0190","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.4049\/jimmunol.162.9.5041","article-title":"Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor","volume":"162","author":"Hoshino","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2025.117656_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117656_b0200","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.4049\/jimmunol.175.12.8280","article-title":"IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase\/Akt and MEK\/ERK1\/2 pathways","volume":"175","author":"Yoo","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117656_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cyto.2014.05.003","article-title":"Interleukin-18 directly protects cortical neurons by activating PI3K\/AKT\/NF-\u03baB\/CREB pathways","volume":"69","author":"Zhou","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2025.117656_b0210","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbi.2014.02.015","article-title":"Interleukin 18 activates MAPKs and STAT3 but not NF-\u03baB in hippocampal HT-22 cells","volume":"40","author":"Alboni","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"23","key":"10.1016\/j.bcp.2025.117656_b0215","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.bcp.2025.117656_b0220","doi-asserted-by":"crossref","DOI":"10.1002\/clc.24229","article-title":"Prognostic significance of IL-18 in acute coronary syndrome patients","volume":"47","author":"Xiong","year":"2024","journal-title":"Clin. Cardiol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117656_b0225","doi-asserted-by":"crossref","first-page":"7997","DOI":"10.4049\/jimmunol.0802884","article-title":"Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4\/MyD88 and the cGMP-dependent protein kinase pathway","volume":"182","author":"Zhang","year":"2009","journal-title":"J. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225009219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225009219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:13:15Z","timestamp":1781698395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225009219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":45,"alternative-id":["S0006295225009219"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117656","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-18 potentiates platelet activation and thrombosis through IL-18R\u03b1-dependent MAPKs and PI3K\/Akt signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117656"}}